Inclusion Criteria:

- Healthy volunteers only

- Males/females, >/=50 and
- Cancer patients only

- Males/females >/= 35 years and
- Patient had an FDG PET/CT for detection, or staging, or restaging, or therapy
response assessment that still showed tumor mass

Exclusion Criteria:

- Concurrent severe and/or uncontrolled and/or unstable other medical disease (e.g.
poorly controlled diabetes, congestive heart failure, myocardial infarction within 12
months prior to planned injection of BAY85-8050, unstable and uncontrolled
hypertension, chronic renal or hepatic disease, severe pulmonary disease) which could
compromise participation in the study

- Known sensitivity to the study drug or components of the preparation